Literature DB >> 15838394

Overview of sarcomas in the adolescent and young adult population.

Cynthia E Herzog1.   

Abstract

Based on the data of the Surveillance, Epidemiology and End Results Section of the National Cancer Institute (SEER) program, soft tissue and bone sarcomas account for about 1% of all new malignancies diagnosed in the United States each year. However, there are numerous different histologic types, and any given type of sarcoma is extremely rare. Determining the incidence of sarcomas by age and type is difficult due to the limited data reported. The SEER program collects data regarding age but only limited data on histology, while most series reported in the literature include either adults or pediatric patients, but rarely both. In an effort to estimate the frequency and absolute numbers of different sarcomas in the adolescent and young adult population, the University of Texas M. D. Anderson Cancer Center (MDACC) tumor registry was queried for all soft tissue sarcomas from 1990 through 2003, and all bone sarcomas from 1990 through 2002. Based on this query, an overview of sarcomas that occur predominantly in the adolescent and young adult (AYA) population is presented. These sarcomas include rhabdomyosarcoma, synovial sarcoma, neurogenic sarcoma, epithelioid sarcomas, alveolar soft parts sarcoma, Ewing sarcoma, and osteosarcoma. Using the percentages for occurrence of each histologic type determined from the MDACC database, and the SEER estimate of overall sarcoma incidence, an estimate of the number of new cases in 2004 for the predominant histologic types occurring in the AYA population are presented. Also reviewed are the chromosomal translocations that occur frequently in sarcomas presenting in the AYA population.

Entities:  

Mesh:

Year:  2005        PMID: 15838394     DOI: 10.1097/01.mph.0000161762.53175.e4

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  68 in total

1.  Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing's sarcoma.

Authors:  Karim Z Masrouha; Khaled M Musallam; Alexis Bou Samra; Ayman Tawil; Rachid Haidar; Zaher Chakhachiro; Said Saghieh; Abeer Abdallah; Raya Saab; Samar Muwakkit; Miguel R Abboud; Nabil J Khoury
Journal:  Skeletal Radiol       Date:  2012-03-10       Impact factor: 2.199

2.  The Impact of Microenvironment on the Synovial Sarcoma Transcriptome.

Authors:  Huifeng Jin; Jared J Barrott; Matthew G Cable; Michael J Monument; Daniel M Lerman; Kyllie Smith-Fry; Dakota Nollner; Kevin B Jones
Journal:  Cancer Microenviron       Date:  2017-04-13

Review 3.  Novel therapeutic approaches in pediatric and young adult sarcomas.

Authors:  Peter M Anderson; Margaret Pearson
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

Review 4.  The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas.

Authors:  Said Saghieh; Karim Z Masrouha; Khaled M Musallam; Rami Mahfouz; Miguel Abboud; Nabil J Khoury; Rachid Haidar
Journal:  Iowa Orthop J       Date:  2010

5.  Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1.

Authors:  Rieko Oyama; Fusako Kito; Marimu Sakumoto; Kumiko Shiozawa; Shunichi Toki; Makoto Endo; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-04-06       Impact factor: 2.416

6.  Embryonal rhabdomyosarcoma of the testis.

Authors:  Brian Kelly; Dara Lundon; Babatunde Rowaiye; Padraig Daly; Kilian Walsh
Journal:  Can Urol Assoc J       Date:  2011-02       Impact factor: 1.862

7.  Conditioned media from mouse osteosarcoma cells promote MC3T3-E1 cell proliferation using JAKs and PI3-K/Akt signal crosstalk.

Authors:  Kanji Mori; Frederic Blanchard; Celine Charrier; Severine Battaglia; Kosei Ando; Laurence Duplomb; Leonard D Shultz; Francoise Redini; Dominique Heymann
Journal:  Cancer Sci       Date:  2008-10-18       Impact factor: 6.716

8.  Principles and Recommendations for the Provision of Healthcare in Canada to Adolescent and Young Adult-Aged Cancer Patients and Survivors.

Authors:  Conrad Fernandez; Graeme A M Fraser; Carolyn Freeman; Eva Grunfeld; Abha Gupta; Leslie Stephen Mery; Sonja De Pauw; Brent Schacter
Journal:  J Adolesc Young Adult Oncol       Date:  2011-04       Impact factor: 2.223

9.  The Influential Role of BCL2 Family Members in Synovial Sarcomagenesis.

Authors:  Jared J Barrott; Ju-Fen Zhu; Kyllie Smith-Fry; Asia M Susko; Dakota Nollner; Lance D Burrell; Amir Pozner; Mario R Capecchi; Jeffrey T Yap; Lisa A Cannon-Albright; Xingming Deng; Kevin B Jones
Journal:  Mol Cancer Res       Date:  2017-08-29       Impact factor: 5.852

Review 10.  RANKL/RANK/OPG: key therapeutic target in bone oncology.

Authors:  Kosei Ando; Kanji Mori; Francoise Rédini; Dominique Heymann
Journal:  Curr Drug Discov Technol       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.